Received Jan 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Suspected vaccination failure; got Ramsey Hunt Syndrome; shingles in my mouth; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), ramsay-hunt syndrome (Verbatim: got Ramsey Hunt Syndrome) (serious criteria GSK medically significant) and oral herpes zoster (Verbatim: shingles in my mouth). The outcome of the vaccination failure, ramsay-hunt syndrome and oral herpes zoster were not reported. It was unknown if the reporter considered the vaccination failure, ramsay-hunt syndrome and oral herpes zoster to be related to Shingles vaccine. The company considered the vaccination failure and ramsay-hunt syndrome to be unrelated to Shingles vaccine. It was unknown if the company considered the oral herpes zoster to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 19-JAN-2026 This case was reported by a patient via interactive digital media. The patient got the shingles shot, got ended up with shingles in the mouth. To top it all off got Ramsey hunt syndrome because of it and then facial synkinesis. The shot was doing not work for patient. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The batch number was not provided and we and unable to contact the reporter.; Sender's Comments: A case of Vaccination failure and Herpes zoster oticus, unknown time after receiving Shingles vaccine, in a patient. Case lacks further information on completion of primary vaccination schedule, time to onset and laboratory confirmation. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.